Vancouver, Canada — December 4, 2025 — Renaissance BioScience Corp., a global leader in bioengineered yeast for the agriculture, food, environmental and energy industries, is pleased to announce the grant of another patent for its innovative yeast-based platform technology that enables low-cost production and effective delivery of RNA. Awarded by the Mexican patent office, this is the third patent issued for the company’s RNA technology following earlier grants in China and Australia, with additional jurisdictions pending. This new patent expands Renaissance’s robust IP portfolio of issued and pending patents for yeast-based technology patents across multiple end-use markets.
Renaissance’s most advanced commercial application of this RNA production and delivery system is a suite of RNAi-based biopesticide products that provide precise, targeted pest control. These products offer a strong environmental safety profile compared with broad-spectrum chemical pesticides, while maintaining competitive production costs at scale. Equally importantly, the technology integrates smoothly into current farming practices and equipment.
Dr.
John Husnik, Renaissance’s CSO and Office of the CEO, commented on the new
patent: “This patent from the Mexican office confirms the novelty and
importance of our yeast-based RNA technology for producing, protecting and
delivering next-generation RNA bioactive molecules. In addition to biopesticides,
this platform offers exciting opportunities across a wide range of multi-billion-dollar
commercial markets.”
About Renaissance BioScience Corp. Based in Vancouver, Canada, Renaissance is a global leading yeast
bioengineering company developing innovative, market-ready, functional
microorganisms that provide cost-effective solutions to address environmental
and industrial challenges in agriculture, animal and human health, food, energy,
and more. More information: www.renaissancebioscience.com.
For media information: Steve Campbell Campbell & Company Strategies Inc.
For
commercial inquiries: Sam Lee, PhD Business Development & Strategy Renaissance BioScience Corp. slee@renaissancebioscience.com
